Brunilda Shtylla - 01 Mar 2023 Form 3 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
Chief Business Officer
Signature
/s/ Edward C. Albini as attorney-in-fact for Brunilda Shtylla
Issuer symbol
STRO
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
3
Filing time
07 Mar 2023, 15:52:04 UTC
Next filing
07 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding STRO Common Stock 17,952 01 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding STRO Stock Option (right to buy) 01 Mar 2023 Common Stock 281 $15.00 Direct F1
holding STRO Stock Option (right to buy) 01 Mar 2023 Common Stock 4,219 $15.00 Direct F1
holding STRO Stock Option (right to buy) 01 Mar 2023 Common Stock 175,000 $11.80 Direct F1
holding STRO Stock Option (right to buy) 01 Mar 2023 Common Stock 30,000 $21.11 Direct F2
holding STRO Stock Option (right to buy) 01 Mar 2023 Common Stock 28,000 $8.17 Direct F3
holding STRO Restricted Stock Unit (RSU) 01 Mar 2023 Common Stock 13,125 Direct F4, F5
holding STRO Restricted Stock Unit (RSU) 01 Mar 2023 Common Stock 27,000 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested and exercisable.
F2 The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.
F3 The option vests as to 2.0833% of the total shares monthly, beginning on April 4, 2022, with 100% of the total shares vested and exercisable on March 4, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
F4 The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.
F5 Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F6 The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney